Preventive effect of compression on breast cancer–related lymphedema after docetaxel chemotherapy: a randomized controlled trial

npj Breast Cancer · Published 2026-08-05 · DOI 10.1038/s41523-026-01011-1

Free full text

Authors (5)

Seung Mi Yeo, Ji Young Lim, Ji-Yeon Kim, Young-Hyuck Im, Ji Hye Hwang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Yeo, S., Lim, J., Kim, J., et al. (2026). Preventive effect of compression on breast cancer–related lymphedema after docetaxel chemotherapy: a randomized controlled trial. npj Breast Cancer. https://doi.org/10.1038/s41523-026-01011-1

Related articles

• Risk factors and metastatic sites in HER2-positive breast cancer with pathological complete response · npj Breast Cancer · 2026 · Same journal
• Anlotinib-containing regimens in HR+ advanced breast cancer after prior CDK4/6 inhibitor progression · npj Breast Cancer · 2026 · Same journal
• Clinical significance of residual microcalcifications after neoadjuvant chemotherapy: MRI response and the subtypes · npj Breast Cancer · 2026 · Same journal
• Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial · npj Breast Cancer · 2026 · Same journal
• Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring · npj Breast Cancer · 2026 · Same journal
• Facing death: the last drawings of a woman with breast cancer at the end of life · npj Breast Cancer · 2026 · Same journal
• Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment response · npj Breast Cancer · 2026 · Same journal
• PCSK9 rs562556 variant and survival in BRCA1 mutation carriers and mutation-negative familial breast cancer · npj Breast Cancer · 2026 · Same journal
• Patient-reported outcomes as early indicators of recurrence, disease progression, and survival via machine learning in breast cancer · npj Breast Cancer · 2026 · Same journal
• External validation of four breast cancer risk prediction models for personalized screening in a prospective Dutch screening cohort · npj Breast Cancer · 2026 · Same journal